DuoDerm Sealing defect (2021-08-20)

Labelling and packaging

Date

2022-05-04

Country

Canada

Classification

Type II

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2022-05-09
2. CA
   Drugs & medical

   COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine): New Formulation/Presentation for Use in Individuals 12 Years of Age and Older

   New safety information

   Health CanadaOfficial notice →
3. CA
   Drugs & medicalType II

   Fore-Sight Elite Tissue Oximeter Module

   Inaccurate test or measurement results

   Health CanadaOfficial notice →
4. 2022-05-05
5. CA
   Drugs & medicalType III

   AA-FENO-SUPER: Product Quality

   Product quality

   Health CanadaOfficial notice →
6. 2022-05-04
7. CA
   Drugs & medicalType II

   Nimbus 4 & Nimbus Professional mattresses (2021-04-13)

   Manufacturing defect

   Health CanadaOfficial notice →
8. 2022-05-03
9. CA
   Drugs & medicalType II

   Somatom Force

   Software defect

   Health CanadaOfficial notice →
10. CA
    Drugs & medicalType II

    Bd Anti-Kappa Pe

    Manufacturing defect

    Health CanadaOfficial notice →